BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28251886)

  • 1. Highly Expressed Antisense Noncoding RNA in the INK4 Locus Promotes Growth and Invasion of Renal Clear Carcinoma Cells via the β-Catenin Pathway.
    Li Q; Tian Y; Hu G; Liang Y; Bai W; Li H
    Oncol Res; 2017 Sep; 25(8):1373-1382. PubMed ID: 28251886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA NBAT1 suppresses cell proliferation and migration via miR-346/GSK-3β axis in renal carcinoma.
    Xue S; Wang S; Li J; Guan H; Jiang S; Guo Y; Li Q
    IUBMB Life; 2019 Nov; 71(11):1720-1728. PubMed ID: 31298469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of FSTL3 abates the proliferation and metastasis of renal cell carcinoma via the GSK-3β/β-catenin signaling pathway.
    Sun F; Sun P; Yang X; Hu L; Gao J; Tian T
    Aging (Albany NY); 2021 Sep; 13(18):22528-22543. PubMed ID: 34555811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway.
    Yuan H; Meng X; Guo W; Cai P; Li W; Li Q; Wang W; Sun Y; Xu Q; Gu Y
    Neoplasia; 2015 May; 17(5):410-20. PubMed ID: 26025664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of long non-coding RNA antisense non-coding RNA in the INK4 locus suppresses OVCAR-3 cells proliferation and induction of apoptosis by Wnt/β-catenin.
    Sun L; Cui Y; Jiang K; Li J
    J Pharm Pharmacol; 2021 Aug; 73(9):1212-1217. PubMed ID: 33772549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
    Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
    Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC01510 suppresses cell proliferation and invasion by inhibiting Wnt/β-catenin signaling in renal cell carcinoma.
    Ma B; Zhang J; Zhou W; Chu C; Zhao C; Zhang Z; Huang T
    Biochem Biophys Res Commun; 2018 Oct; 505(1):7-12. PubMed ID: 30224058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.
    Hsu RJ; Ho JY; Cha TL; Yu DS; Wu CL; Huang WP; Chu P; Chen YH; Chen JT; Yu CP
    PLoS One; 2012; 7(10):e47649. PubMed ID: 23094073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of long noncoding RNA DLEU1 suppresses the progression of renal cell carcinoma by downregulating the Akt pathway.
    Yue G; Chen C; Bai L; Wang G; Huang Y; Wang Y; Cui H; Xiao Y
    Mol Med Rep; 2019 Nov; 20(5):4551-4557. PubMed ID: 31702026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of PLOD3 suppresses the malignant progression of renal cell carcinoma via reducing TWIST1 expression.
    Xie D; Li J; Wei S; Qi P; Ji H; Su J; Du N; Zhang X
    Mol Cell Probes; 2020 Oct; 53():101608. PubMed ID: 32585183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
    Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
    Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH
    Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA ENST00000434223 inhibits the progression of renal cancer through Wnt/hygro-catenin signaling pathway.
    Luo NQ; Ma DR; Yang XC; Liu Y; Zhou P; Guo LJ; Huang XD
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6868-6877. PubMed ID: 31486486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X; Yu JJ
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA BX357664 regulates cell proliferation and epithelial-to-mesenchymal transition via inhibition of TGF-β1/p38/HSP27 signaling in renal cell carcinoma.
    Liu Y; Qian J; Li X; Chen W; Xu A; Zhao K; Hua Y; Huang Z; Zhang J; Liang C; Su S; Li P; Shao P; Li J; Qin C; Wang Z
    Oncotarget; 2016 Dec; 7(49):81410-81422. PubMed ID: 27806310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
    Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
    Wu C; Zhang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
    Ma J; Li T; Han X; Yuan H
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA POU3F3 Promotes Cancer Cell Proliferation, Migration, and Invasion in Renal Cell Carcinoma by Downregulating LncRNA GAS5.
    Zhang L; Wang C; Ma M
    Kidney Blood Press Res; 2021; 46(5):613-619. PubMed ID: 34352801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.